1. Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial. Issue 8 (August 2020) Authors: Gaur, Aditya H; McCarthy, James S; Panetta, John C; Dallas, Ronald H; Woodford, John; Tang, Li; Smith, Amber M; Stewart, Tracy B; Branum, Kristen C; Freeman, Burgess B; Patel, Nehali D; John, Elizabeth; Chalon, Stephan; Ost, Shelley; Heine, Ryan N; Richardson, Julie L; Christensen, Robbin; Flynn,... Journal: Lancet infectious diseases Issue: Volume 20:Issue 8(2020) Page Start: 964 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗